Literature DB >> 1104475

Experimental murine leprosy: induction of immunity and immune paralysis to Mycobacterium lepraemurium in C57BL mice.

O Closs.   

Abstract

Two series of reinfection experiments were carried out using C57BL mice. In the first series, the mice were inoculated with Mycobacterium lepraemurium (MLM) in one hind footpad and reinoculated in the contralateral footpad, two or four weeks later. Compared with normal mice of the same strain, the mice reinoculated after four weeks showed an increased local reaction to the bacilli and the bacilli did not multiply at the injection site. The responses of mice reinoculated after two weeks were intermediate to those of the other two groups. In the second series, a systemic infection was established by intraperitoneal innoculation of either a large or small dose of MLM. Twenty-two weeks later the mice were reinoculated in one of the hind footpads. Upon reinoculation, mice receiving the small intraperitoneal dose reacted more strongly than normal mice to MLM, whereas mice receiving the large dose were unable to mount any local reaction to the mycobacterium. The experiments have shown that the local reaction which develops in the C57BL strain of mice approximately four weeks after subcutaneous injection of MLM is accompanied by the onset of systemic immunity. Such systemic immunity lasted for more than 20 weeks after intraperitoneal injection of a small dose of bacilli, but was completely abolished during the course of a heavy systemic MLM infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104475      PMCID: PMC415345          DOI: 10.1128/iai.12.4.706-713.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Effect of macrocyclon in acute and chronic pulmonary tuberculous infection in mice as shown by viable and total bacterial counts.

Authors:  P D HART; R J REES
Journal:  Br J Exp Pathol       Date:  1960-08

2.  Fate of tubercle bacilli in early experimental infection of the mouse.

Authors:  D F GRAY
Journal:  J Hyg (Lond)       Date:  1959-12

3.  Classification of mouse leprosy.

Authors:  Y KAWAGUCHI
Journal:  Jpn J Exp Med       Date:  1959-12

4.  The pathogenesis of the early skin lesion in leprosy.

Authors:  D S Ridley
Journal:  J Pathol       Date:  1973-11       Impact factor: 7.996

5.  Mechanisms of reactions in leprosy.

Authors:  M F Waters; J L Turk; S N Wemambu
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Apr-Jun

6.  Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

7.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

8.  Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response.

Authors:  W E Bullock; P Fasal
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

9.  Experimental murine leprosy. 2. Further evidence for varying susceptibility of outbred mice and evaluation of the response of 5 inbred mouse strains to infection with Mycobacterium lepraemurium.

Authors:  O Closs; O A Haugen
Journal:  Acta Pathol Microbiol Scand A       Date:  1974-07

10.  T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis.

Authors:  R J North
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  18 in total

1.  Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis.

Authors:  M Harboe; H G Wiker; J R Duncan; M M Garcia; T W Dukes; B W Brooks; C Turcotte; S Nagai
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  Relationship between delayed-type hypersensitivity and the progression of Mycobacterium lepraemurium infection.

Authors:  L W Poulter; M J Lefford
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

Review 3.  Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.

Authors:  G Bjune; O Closs; R S Barnetson
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity.

Authors:  M Løvik; O Closs
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  A lack of correlation between antigen-specific cellular reactions and resistance to Mycobacterium lepraemurium infection in mice.

Authors:  J Curtis; H O Adu; J L Turk
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

6.  Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy.

Authors:  R Turcotte; J Chaput; S Lemieux
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Lymphocyte transformation test in leprosy: decreased lymphocyte reactivity to Mycobacterium leprae in lepromatous leprosy, with no evidence for a generalized impairment.

Authors:  W R Faber; D L Leiker; I M Nengerman; W P Zeijlemaker; P T Schellekens
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.

Authors:  M J Lefford; P J Patel; L W Poulter; G B Mackaness
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Suppression of immunity to Mycobacterium lepraemurium infection.

Authors:  M J Lefford; G B Mackaness
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.